Patent 7745629 was granted and assigned to Vertex Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.
The present invention relates to bicyclic compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.